New Innovations for EPA 8260 Analysis
June 1st 2009Over the past 15 years, little has changed for the commercial environmental laboratory's ability to automate U.S. EPA Method 8260 for water and soil purge and trap analysis. As work loads have increased, reporting levels have decreased due to MS sensitivity improvements. However, it has become increasingly difficult for laboratories to run at high levels of productivity due to autosampler reliability, carryover, and internal standard reproducibility challenges. Each of these issues has been addressed in a new Centurion WS autosampler (see Figure 1) designed specifically for the commercial environmental laboratory.
Comparison of Fully and Superficially Porous Particle Columns for the Analysis of Basic Compounds
June 1st 2009Since the introduction of high-performance liquid chromatography (HPLC) nearly 40 years ago, many improvements have been made to column stationary phases to achieve faster, more efficient separations. HPLC columns containing superficially porous (sometimes called fused-core) particles have recently gained increasing attention. Though this technology is not entirely new, it has been improved to the point where rapid, highly efficient separations can be achieved for some applications.
Identifying Drugs of Abuse Using Gas Chromatography-Time of Flight Mass Spectrometry (GC-TOFMS)
June 1st 2009Illegal drug use worldwide is at an all time high. Forensic laboratories are seeing increased sample loads creating an immediate need for fast and accurate analysis to positively identify confiscated materials in criminal investigations. This application highlights the value of gas chromatography with time-of-flight mass spectrometry (GC-TOFMS) for drug testing in forensic laboratories. A method was developed to successfully identify twenty drugs of abuse in 4.5 min. This GC-TOFMS method shows good chromatographic peak shape for even the most challenging drug analytes; even the peak shapes for amphetamine and methamphetamine were exceptional considering they were analyzed underivatized. The total ion chromatogram (TIC) for the twenty drug analytes is shown in Figure 1.
Determination of UV Absorbers from Sunscreens by UHPLC with Photodiode Array Detection
June 1st 2009Measure UV-absorbing compounds in consumer products and characterize the UV absorption spectra of the individual components by employing high-speed liquid chromatography with photodiode array detection.
Flexible Fused Silica Capillary: A Discussion of Strength
June 1st 2009Synthetic fused silica capillary tubing is a vital component in many scientific techniques. The general perception is that most laboratory glass products are fragile and easy to break. The opposite is true of fused silica capillary; with its protective coating it is both strong and durable when handled properly.
Simultaneous Separation of Pharmaceutical Counterions on a Tri-Mode HPLC Column
June 1st 2009Salt formation is a critical aspect in drug development (1) and HPLC is an important tool for determination of pharmaceutical counterions. Reversed-phase columns often fail to retain very hydrophilic counterions. Ion chromatography (IC) is preferred for selective and sensitive screening of cationic and anionic pharmaceutical counterions (2), usually with multiple runs. Positive and negative counterions can be separated simultaneously using a zwitterionic HILIC column using an evaporative light scattering detector (3). However, the zwitterionic column method has limitations: 1) limited to HILIC mode; 2) ions are retained as salts rather than via ion-exchange, making method development difficult; and 3) the method is not suitable for simultaneous separation of acidic, basic, and neutral analytes.
Direct Determination of Mannose-6-Phosphate Content of Glycoproteins
June 1st 2009D-Mannose-6-phosphate (M-6-P) is a terminal monosaccharide of some asparagine-linked (N-linked) oligosaccharides and is also part of an important intermediate in N-linked oligosaccharide biosynthesis. Some lysosomal glycoproteins require M-6-P terminated oligosaccharides for proper targeting and function. Lack of M-6-P or genetic defects in its synthesis or subsequent processing can result in a variety of diseases.